Everolimus

Overview

Everolimus is an inhibitor of mammalian target of rapamycin (mTOR) with an immunosuppressive activity which is comparable to that of rapamycin. It inhibits cytokine-mediated lymphocyte proliferation. Everolimus can be used as an immunosuppressant in the treatment of renal cell cancer and other cancers. Source summary: Everolimus is an mTOR inhibitor widely used in research to explore its role in cellular growth, proliferation, and survival pathways. Inquire now for detailed insights!

Application

Products > Drug Discovery > Impurities > Anti-Neoplastic > Everolimus and Impurities | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B1335-476235
• CAS No.: 159351-69-6
• Molecular Formula: C53H83NO14
• Molecular Weight: 958.24
• Purity: >98%
• Storage: Store at -20°C
• Solubility: Soluble in ethanol, methanol, DMF, DMSO

Source

Original product source